Olink Spin-Out Q-linea Will Aim to Make Its Flow Cytometry Tech Work with Array Methods | GenomeWeb
Q-linea, a recent spin-out of Swedish biotechnology company Olink Bioscience, last week said its first corporate goal is to develop a flow cytometry-based field-deployable detection system for biodefense applications that will eventually work together with microarrays.
 
“One option we are discussing right now is to have Q-linea as an early-stage platform and then you could have detection performed on an array at a later stage,” CEO Jonas Jarvius told BioArray News this week.
 

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Science this week: deletion of one microRNA allows pluripotent stem cells to form embryonic and non-embryonic lineages, and more.

Arizona is planning to sue Theranos for "deceptive acts" and misrepresentations of its "capabilities and operation."

If confirmed as Department of Health and Human Services Secretary, Tom Price says he will divest himself of certain holdings, according to Stat News.

Oliver Smithies, who won the Nobel Prize in 2007, has died, the New York Times reports.